Related Experiment Video
Updated: May 4, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Iron-refractory microcytic anemia as the presenting feature of unicentric Castleman disease in children
Shanmuganathan Chandrakasan1, Nihal Bakeer1, Jun Qin Mo2
1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Abstract:
Chronic, iron-refractory, microcytic anemia can be a diagnostic and therapeutic challenge. We report the cases of 2 children with occult, unicentric Castleman disease whose primary presenting feature was a chronic, unexplained, iron-refractory, microcytic anemia. Diagnosis was delayed because neither child had palpable lymphadenopathy and the lymphoproliferation was intra-abdominal. Surgical resection cured the anemia and the Castleman disease. A diagnostic clue to Castleman disease is an elevated concentration of interleukin-6 in blood, which causes anemia by inducing the expression of the iron-regulatory hormone hepcidin.
Insights
Unexplained iron-refractory anemia in children can signal occult Castleman disease. Surgical removal of the intra-abdominal tumor resolved both the cancer and the anemia, highlighting interleukin-6
Area of Science:
- Pediatric Hematology
- Oncology
- Immunology
Background:
- Chronic, iron-refractory, microcytic anemia presents diagnostic and therapeutic challenges.
- Castleman disease is a rare lymphoproliferative disorder that can manifest with anemia.
Observation:
- Two pediatric cases presented with unexplained, chronic, iron-refractory, microcytic anemia as the primary symptom.
- Diagnosis was delayed due to occult, intra-abdominal lymphoproliferation and absence of palpable lymphadenopathy.
Findings:
- Surgical resection of unicentric Castleman disease successfully cured both the anemia and the underlying disease.
- Elevated interleukin-6 (IL-6) levels were identified as a key diagnostic clue, correlating with anemia induction via hepcidin.
Implications:
- Highlights the importance of considering Castleman disease in pediatric patients with refractory anemia.
- Suggests IL-6 as a potential biomarker for Castleman disease-associated anemia.
- Demonstrates the curative potential of surgical intervention for this specific presentation of Castleman disease.
More Related Videos
09:40Identification of a Murine Erythroblast Subpopulation Enriched in Enucleating Events by Multi-spectral Imaging Flow Cytometry
Published on: June 6, 2014
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Related Concept Videos
Cytomegalovirus Disease
Chronic Kidney Disease II: Clinical Manifestations
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Endocarditis II: Clinical Features of Infective Endocarditis